Neoplants is a biotechnology company specializing in the development of plant-based solutions for various industries. The company leverages synthetic biology to engineer plants that can absorb and sequester carbon dioxide more efficiently, aiming to combat climate change. Additionally, Neoplants explores the potential of plants in producing high-value compounds for applications in pharmaceuticals, cosmetics, and agriculture.

Neoplants

Partech is a global tech investment firm headquartered in Paris, with offices in Berlin, Dakar, Dubai, Nairobi, and San Francisco. We are a team made up of independent thinkers. We are unconstrained by hype, trend or fixed ways of working. We believe in the power of alliance in action, working together and side-by-side with the founders we back, in the shared pursuit of success. We bring together capital, operational experience and strategic support for the entrepreneurs we back from seed through to growth stage. Born in San Francisco 40 years ago, today we manage €2.5bn AUM and our current portfolio of 220 companies in 40 countries, across 4 continents.

COM:PARTECHPARTNERS

Neoplants

Financials Not Available